Whole‐exome sequencing (WES) of eight primary SPNs confirmed that they have nearly universal mutation of CTNNB1 and demonstrated that these tumours have a low mutational burden and infrequent copy‐number changes compared with pancreatic adenocarcinoma 7. This evidence concerns the gene CTNNB1 and neoplasm.